ReviewPharmaceutics2022

Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective.

Felix Aberer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.